Bank Julius Baer & Co’s Beam Therapeutics BEAM Stock Holding History

Bank Julius Baer & Co’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.7K	Hold	1,710	–	–	﹤0.01%	579
2026 Q1	$40.7K	Hold	1,710	–	–	﹤0.01%	609
2025 Q4	$47.4K	Buy	+1,710	New	+$43.6K	﹤0.01%	588
2022 Q2	–	Sell	-2,653	Closed	-$152K	–	601
2022 Q1	$152K	Buy	+2,653	New	+$174K	﹤0.01%	449
2021 Q2	–	Sell	-13,268	Closed	-$1.06M	–	822
2021 Q1	$1.06M	Buy	+13,268	New	+$1.26M	0.01%	332

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Bank Julius Baer & Co's BEAM Position: Q2 2026 in Review

Bank Julius Baer & Co held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 1,710 shares worth $58.7K. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Bank Julius Baer & Co first reported a position in BEAM in Q1 2021 and has held it in 5 quarters since. The position peaked at $1.06M in Q1 2021. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Bank Julius Baer & Co held 1,710 shares of Beam Therapeutics worth $58.7K as of Q2 2026.
Bank Julius Baer & Co left its Beam Therapeutics share count unchanged in Q2 2026.
Beam Therapeutics made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #579 holding.
Bank Julius Baer & Co first reported a position in Beam Therapeutics in Q1 2021 and has held it in 5 quarters since.
Bank Julius Baer & Co's Beam Therapeutics position peaked at $1.06M in Q1 2021.
278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.